Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors.
affinity
anticancer
docking
selectivity
sigma 1 receptor
sigma 2 receptor
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
06 Jun 2024
06 Jun 2024
Historique:
received:
08
05
2024
revised:
31
05
2024
accepted:
03
06
2024
medline:
19
6
2024
pubmed:
19
6
2024
entrez:
19
6
2024
Statut:
epublish
Résumé
Sigma receptors (SRs), including SR1 and SR2 subtypes, have attracted increasing interest in recent years due to their involvement in a wide range of activities, including the modulation of opioid analgesia, neuroprotection, and potential anticancer activity. In this context, haloperidol (HAL), a commonly used antipsychotic drug, also possesses SR activity and cytotoxic effects. Herein, we describe the identification of novel SR ligands, obtained by a chemical hybridization approach. There wereendowed with pan-affinity for both SR subtypes and evaluated their potential anticancer activity against SH-SY5Y and HUH-7 cancer cell lines. Through a chemical hybridization approach, we identified novel compounds (
Identifiants
pubmed: 38893570
pii: molecules29112697
doi: 10.3390/molecules29112697
pii:
doi:
Substances chimiques
Receptors, sigma
0
Haloperidol
J6292F8L3D
Antineoplastic Agents
0
Ligands
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM